# Trevi Therapeutics Inc. (TRVI)

Source: https://www.quantisnow.com/company/TRVI
Generated: 2026-11-18T12:33:56.794Z

- Ticker: TRVI
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2019
- SEC CIK: 0001563880
- Website: trevitherapeutics.com

## About

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, which is in Phase IIb/III clinical trial is an oral extended release formulation of nalbuphine that is used for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson's disease, as well as to treat chronic kidney disease-associated with pruritus. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation; and Rutgers to develop and commercialize products incorporating nalbuphine for any human or animal use. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.

## Latest TRVI news and filings

- 2026-11-16 21:19 UTC [SEC Schedule 13G] [Amendment: SEC Form SCHEDULE 13G/A filed by Trevi Therapeutics Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-trevi-therapeutics-inc-6794311)
- 2026-11-09 21:27 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Trevi Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-trevi-therapeutics-inc-6781643)
- 2026-11-09 21:26 UTC [SEC Form 8-K] [Trevi Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/trevi-therapeutics-inc-filed-sec-form-8-k-results-of-operations-6781630)
- 2026-11-09 21:05 UTC [Earnings] [Trevi Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates](https://www.quantisnow.com/insight/trevi-therapeutics-reports-third-quarter-2026-financial-results-and-provides-6781154)
- 2026-11-02 21:05 UTC [Earnings Date] [Trevi Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 9, 2026](https://www.quantisnow.com/insight/trevi-therapeutics-to-report-third-quarter-2026-financial-results-and-6766993)
- 2026-10-27 11:30 UTC [Conference Announcement] [Trevi Therapeutics to Participate in Stifel's 2026 Healthcare Conference](https://www.quantisnow.com/insight/trevi-therapeutics-to-participate-in-stifels-2026-healthcare-conference-6758477)
- 2026-10-13 11:30 UTC [Trevi Therapeutics Announces Oral Presentation Accepted at the CHEST 2026 Annual Meeting](https://www.quantisnow.com/insight/trevi-therapeutics-announces-oral-presentation-accepted-at-the-chest-2026-6744112)
- 2026-09-17 20:55 UTC [SEC Form 4] [Director Heffernan Michael Thomas exercised 39,473 shares at a strike of $3.19 and sold $595,806 worth of shares (39,473 units at $15.09) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/director-heffernan-michael-thomas-exercised-39473-shares-at-a-strike-6719502)
- 2026-09-15 20:42 UTC [SEC Form 144] [SEC Form 144 filed by Trevi Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-trevi-therapeutics-inc-6716339)
- 2026-09-03 11:30 UTC [Conference Announcement] [Trevi Therapeutics to Participate in Upcoming September Conferences](https://www.quantisnow.com/insight/trevi-therapeutics-to-participate-in-upcoming-september-conferences-6704188)
- 2026-08-26 11:30 UTC [Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026](https://www.quantisnow.com/insight/trevi-therapeutics-announces-upcoming-presentations-at-the-european-respiratory-society-6694953)
- 2026-08-06 20:16 UTC [SEC Form S-8] [SEC Form S-8 filed by Trevi Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-trevi-therapeutics-inc-6669300)
- 2026-08-06 20:12 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Trevi Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-trevi-therapeutics-inc-6669157)
- 2026-08-06 20:08 UTC [SEC Form 8-K] [Trevi Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/trevi-therapeutics-inc-filed-sec-form-8-k-results-of-operations-6668964)
- 2026-08-06 20:05 UTC [Public Offering] [Trevi Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates](https://www.quantisnow.com/insight/trevi-therapeutics-reports-second-quarter-2026-financial-results-and-provides-6668757)
- 2026-08-06 14:43 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Trevi Therapeutics Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-trevi-therapeutics-inc-6668158)
- 2026-07-30 20:05 UTC [Earnings Date] [Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026](https://www.quantisnow.com/insight/trevi-therapeutics-to-report-second-quarter-2026-financial-results-and-6655963)
- 2026-07-28 11:30 UTC [Conference Announcement] [Trevi Therapeutics to Participate in Upcoming August Conferences](https://www.quantisnow.com/insight/trevi-therapeutics-to-participate-in-upcoming-august-conferences-6650610)
- 2026-07-21 12:10 UTC [Analyst Coverage Initiated] [BMO Capital Markets initiated coverage on Trevi Therapeutics with a new price target](https://www.quantisnow.com/insight/bmo-capital-markets-initiated-coverage-on-trevi-therapeutics-with-a-6643339)
- 2026-06-17 11:30 UTC [Trevi Therapeutics Announces Upcoming June and July Event Schedule](https://www.quantisnow.com/insight/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule-6605846)
- 2026-06-04 20:28 UTC [SEC Form 4] [SEC Form 4 filed by Director Mathers Edward T](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-mathers-edward-t-6589596)
- 2026-06-04 20:05 UTC [SEC Form 8-K] [Trevi Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/trevi-therapeutics-inc-filed-sec-form-8-k-leadership-update-amendments-6589289)
- 2026-06-04 20:05 UTC [SEC Form 4] [SEC Form 4 filed by Director Colangelo Dominick](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-colangelo-dominick-6589265)
- 2026-06-04 20:05 UTC [SEC Form 4] [SEC Form 4 filed by Director Vanlent Anne](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-vanlent-anne-6589252)
- 2026-06-04 20:05 UTC [SEC Form 4] [SEC Form 4 filed by Director Heffernan Michael Thomas](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-heffernan-michael-thomas-6589251)
- 2026-06-04 20:05 UTC [SEC Form 4] [SEC Form 4 filed by Director Meeker David P](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-meeker-david-p-6589244)
- 2026-05-06 15:40 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Trevi Therapeutics Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-trevi-therapeutics-inc-6534756)
- 2026-05-05 20:09 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Trevi Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-trevi-therapeutics-inc-6532121)
- 2026-05-05 20:07 UTC [SEC Form 8-K] [Trevi Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/trevi-therapeutics-inc-filed-sec-form-8-k-results-of-operations-6532055)
- 2026-05-05 20:05 UTC [Public Offering] [Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates](https://www.quantisnow.com/insight/trevi-therapeutics-reports-first-quarter-2026-financial-results-and-provides-6531890)
- 2026-04-30 20:05 UTC [Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International Conference](https://www.quantisnow.com/insight/trevi-therapeutics-announces-oral-presentation-and-multiple-posters-accepted-at-6524106)
- 2026-04-28 20:05 UTC [Earnings Date] [Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026](https://www.quantisnow.com/insight/trevi-therapeutics-to-report-first-quarter-2026-financial-results-and-6518443)
- 2026-04-23 20:05 UTC [Conference Announcement] [Trevi Therapeutics to Participate in Upcoming May Events](https://www.quantisnow.com/insight/trevi-therapeutics-to-participate-in-upcoming-may-events-6512355)
- 2026-04-21 20:00 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Trevi Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-trevi-therapeutics-inc-6508271)
- 2026-04-21 20:00 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Trevi Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-trevi-therapeutics-inc-6508260)
- 2026-04-20 20:05 UTC [Public Offering] [Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares](https://www.quantisnow.com/insight/trevi-therapeutics-announces-closing-of-173-million-underwritten-offering-and-6506618)
- 2026-04-17 20:17 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Trevi Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-trevi-therapeutics-inc-6504893)
- 2026-04-17 12:06 UTC [SEC Form 8-K] [Trevi Therapeutics Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/trevi-therapeutics-inc-filed-sec-form-8-k-other-events-6504219)
- 2026-04-17 02:42 UTC [Public Offering] [Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock](https://www.quantisnow.com/insight/trevi-therapeutics-announces-pricing-of-150-million-underwritten-offering-of-6503948)
- 2026-04-16 20:16 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Trevi Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-trevi-therapeutics-inc-6503295)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/TRVI
- Earnings history: https://www.quantisnow.com/earnings/TRVI
- Dividend history: https://www.quantisnow.com/dividends/TRVI
- Insider transactions: https://www.quantisnow.com/insiders/TRVI
- Options chain: https://www.quantisnow.com/options/TRVI
- SEC 8-K filings only: https://www.quantisnow.com/company/TRVI/8-k
- RSS and alerts for TRVI: https://www.quantisnow.com/docs/rss-feeds.md
